Online webinar - Chronic Lymphocytic Leukaemia (CLL) second-line and subsequent treatments
RECORDED ON 5/5/2021. INFORMATION CORRECT AS OF THIS DATE.
In this webinar, we talked about CLL second-line treatments and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should patients expect in their care decisions.
We were joined by:
Dr Tahla Munir, Consultant in Clinical Haematology at Leeds Teaching Hospitals NHS Trust.
Dr Munir’s main clinical and research special interests are in chronic lymphocytic leukaemia, particularly in the assessment of the mechanism of action of novel targeted therapies.
Lianne Palmer, CLL-specific CNS at Oxford University Hospitals.
Lianne Palmer is one of just a handful of CLL-specific clinical nurse specialists across the UK.
If you have any questions about this webinar, please email advocacy@leukaemiacare.org.uk.
-
Category
No comments found